About
UserAgreement
Bylaws
Stewards
Members
Become A Member
Contact
Newsletter
Announcements
Tweets
Podcast
Members Map
Book
Film
Gallery
Videos
Library
Calendar
Links
Quiz
Donate
Store
Projects
₮hank$
cell therapies
0
Athersys (ATHX)
Started by
ImmInst
, Jul 27 2011 04:03 PM
7 replies to this topic
#2 OFFLINE Re: Athersys (ATHX)
- Topic Starter
-
- Registered User, Director bot
- 1,381 posts
- 61 ₮
Posted 11 August 2011 - 04:44 PM
Athersys (ATHX) Reports Rapid Clinical Progress Second Quarter
BiotechStockTrader.com - 2 hours ago
BiotechStockTrader.com - 2 hours ago
By Justin Kuepper on Thursday, August 11th, 2011 Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like ...
View the full article
#3 OFFLINE Re: Athersys (ATHX)
- Topic Starter
-
- Registered User, Director bot
- 1,381 posts
- 61 ₮
Posted 07 September 2011 - 01:35 PM
Why Athersys (ATHX) is a Compelling Investment Opportunity
BiotechStockTrader.com - 2 hours ago
BiotechStockTrader.com - 2 hours ago
Athersys Inc. (NASDAQ: ATHX) is a company focused on regenerative medicine, similar to companies like Osiris Therapeutics Inc. (NASDAQ: OSIR), Mesoblast (ASX:MSB), and Cytori (NASDQ: CYTX) and ...
View the full article
#4 OFFLINE Re: Athersys (ATHX)
- Topic Starter
-
- Registered User, Director bot
- 1,381 posts
- 61 ₮
Posted 30 September 2011 - 07:23 PM
Athersys (ATHX) CEO to Deliver Keynote Address at World Stem Cell Summit 2011
BiotechStockTrader.com - 1 hour ago
BiotechStockTrader.com - 1 hour ago
Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ...
View the full article
#5 OFFLINE Re: Athersys (ATHX)
- Topic Starter
-
- Registered User, Director bot
- 1,381 posts
- 61 ₮
Posted 01 February 2012 - 11:17 PM
Athersys (ATHX) Releases Positive Results From MultiStem® Clinical Trial For ...
SECFilings.com - Feb 1, 2012
SECFilings.com - Feb 1, 2012
Athersys Inc. (NASDAQ: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (ASX: MSB), Verastem Inc. (NASDAQ: VSTM) and Osiris (NASDAQ: OSIR), announced grant funding awards of ...
View the full article
#6 OFFLINE Re: Athersys (ATHX)
- Topic Starter
-
- Registered User, Director bot
- 1,381 posts
- 61 ₮
Posted 06 April 2012 - 08:56 PM
ASX healthcare companies rebound in 2012: Acrux, ResMed, Mesoblast
Proactive Investors Australia - 1 hour ago
Proactive Investors Australia - 1 hour ago
Proactive Investors brings you the latest news on the "Small-Mid Caps" listed on the Australian Securities Exchange. While the broader Australian market may not be performing so well lately due to ongoing eurozone concerns and a tumbling of precious ...
View the full article
#7 OFFLINE Re: Athersys (ATHX)
- Topic Starter
-
- Registered User, Director bot
- 1,381 posts
- 61 ₮
Posted 05 April 2012 - 12:25 AM
Athersys (ATHX) Reports Solid Progress in 2011
BiotechStockTrader.com - Apr 5, 2012
BiotechStockTrader.com - Apr 5, 2012
Athersys Inc. (Nasdaq: ATHX), a clinical stage biotechnology company focused on the development of its proprietary MultiStemŽ cell therapy product for the treatment of numerous diseases and conditions, similar to companies like Mesoblast (MSB: ASX) and ...
View the full article
#8 OFFLINE Re: Athersys (ATHX)
- Topic Starter
-
- Registered User, Director bot
- 1,381 posts
- 61 ₮
Posted 04 April 2012 - 03:38 PM
Athersys (ATHX) Secures New GvHD Patent for MultiStem
BiotechStockTrader.com - Apr 4, 2012
BiotechStockTrader.com - Apr 4, 2012
Athersys Inc. (NASDAQ: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (ASX: MSB), Verastem Inc. (NASDAQ: VSTM) and Osiris (NASDAQ: OSIR), recently announced that it was ...
View the full article
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users
